Classic Hodgkin lymphoma (CHL) was first described in 1832 by Thomas Hodgkin, and is
characterized by a small number of Hodgkin and Reed–Sternberg cells in a rich …

Background Accumulating evidence suggests that risk factors for classical Hodgkin
lymphoma (cHL) differ by tumor Epstein–Barr virus (EBV) status. This potential etiological …

Background and Aims The prevalence and prognostic significance of Epstein-Barr virus
(EBV) infection in classical Hodgkin's lymphomas (cHLs) remain elusive. To examine the …

Various studies have indicated that the human leukocyte antigen (HLA) region is associated
with Hodgkin's lymphoma. We recently showed a specific association of the HLA class I …

BACKGROUND/PURPOSE: Hodgkin's lymphoma (HL) is particularly rare in Asia, including
Taiwan. The report concerning its clinical features and treatment outcomes in Asians is …

The epidemiology of Hodgkin's lymphoma (HL) shows wide geographic variation in
histological subtypes and in its association with the Epstein-Barr virus (EBV). The proportion …

The aim of this paper is to review morphologic, immunophenotypic, and molecular features
of classic Hodgkin lymphoma, as well as different prognostic markers in this neoplasm …

Although the role of the non-classical human leukocyte antigen E (HLA-E) was originally
thought to be limited to the development of a maternal tolerance to a semiallogeneic fetal …

Purpose To investigate the clinical characteristics and treatment outcome of patients with
lymphocyte-rich classical Hodgkin's lymphoma (LRCHL) compared with other histologic …

Classical Hodgkin lymphoma (cHL) is characterized by the presence of tumoral cells in a
rich background of T and B cells, macrophages and other inflammatory cells. The …